Committed to a world WITHOUT Alzheimer’s disease.

Alzheimer’s Therapeutic Research Institute

We are on a path to success in solving the problem of Alzheimer’s Disease (AD). We have a roadmap for our research; build upon amyloid removing treatments, add tau treatments and ultimately prevent the disease altogether.

About Us

Our Impact

We lead the way in AD research

We develop the deepest understanding of the disease and all its stages.

We have a commitment to open science; sharing data to accelerate discoveries.

We create rigorous trial designs and analytical approaches.

Take Action

How YOU Can Make an Impact

Here at ATRI we rely on our community to make a difference when it comes to advancing AD research. You can help be a part of that, whether through direct participation or supporting the Institute.

Participate in a Study

Donate to ATRI

We lead scientific advancements & understanding of Alzheimer’s disease.

Dr. Alois Alzheimer describes disease

Alzheimer’s Disease Cooperative Study (ADCS) launched. Funded by NIA and led by Leon Thal

Anti-Amyloid Treatment in Asymptomatic Alzheimer's study

ATRI founded as a San Diego Institute of USC

Alzheimer’s Clinical Trials Consortium (ACTC) formed. Funded by NIA and led by Aisen, Petersen and Sperling.

Aducanumab receives accelerated approval for treatment of Alzheimer’s disease

View Timeline

Founding director of USC ATRI

Read the Publications

Paul Aisen, MD

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum

Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease

The case for low-level BACE1 inhibition for the prevention of Alzheimer’s disease

Learn More

How can YOU take action

You can help prevent Alzheimer’s. There are a number of ways to take action.

Donate

Participate